Share Price and Basic Stock Data
Last Updated: January 1, 2026, 3:09 pm
| PEG Ratio | -1.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Camex Ltd operates within the specialty chemicals sector, focusing on niche applications that cater to diverse industrial needs. As of the latest reporting period, the company’s stock price stood at ₹33.9, with a market capitalization of ₹34.6 Cr. Over the last few quarters, Camex has shown fluctuations in revenue, with sales reporting ₹30.58 Cr in September 2022, peaking at ₹40.36 Cr in March 2023, before settling at ₹35.22 Cr in September 2023. The company’s overall sales for the trailing twelve months (TTM) are reported at ₹137 Cr, reflecting a slight decrease from ₹162 Cr in March 2022. The trend indicates a recovery phase following a dip in sales during FY 2023, where sales dropped to ₹132 Cr. This recovery is vital for sustaining market confidence and ensuring operational viability in a competitive landscape where specialty chemical firms commonly report steady growth.
Profitability and Efficiency Metrics
Camex Ltd has struggled with profitability, as indicated by its operating profit margin (OPM), which stood at a mere 0.73%. The company reported an operating loss in several quarters, with a significant loss of ₹0.45 Cr in September 2022 and a slight recovery to an operating profit of ₹1.11 Cr by September 2023. Despite these challenges, the company recorded a net profit of ₹0.99 Cr in the same quarter, which is a notable improvement compared to previous periods. The return on equity (ROE) is currently at 4.63%, while return on capital employed (ROCE) stands at 9.07%. These figures indicate a need for improved operational efficiency and cost management, as typical industry benchmarks for ROE often exceed 10%. Additionally, the cash conversion cycle is reported at 51 days, which is on the lower end, suggesting better liquidity management compared to many peers.
Balance Sheet Strength and Financial Ratios
The financial health of Camex Ltd is characterized by a conservative borrowing strategy, with total borrowings reported at ₹6 Cr against reserves of ₹33 Cr. The company maintains a debt-to-equity ratio of 0.18, indicating low leverage, which is generally favorable in the chemicals sector. The interest coverage ratio (ICR) stands at 2.34 times, suggesting that the company can comfortably meet its interest obligations. However, the price-to-book value (P/BV) ratio is recorded at 0.71x, indicating that the stock may be undervalued relative to its book value. This could attract value-focused investors. Moreover, the company’s equity capital has remained stable at ₹10 Cr since 2014, while total assets have increased to ₹62 Cr in March 2025, reflecting growth in the asset base despite the challenges in profitability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Camex Ltd reveals a significant presence of public investors, holding 55.24% of shares as of the most recent report. Promoters have reduced their stake from 58.28% in December 2022 to 44.76% by December 2024, indicating a potential shift in confidence or strategy. Institutional investors, particularly domestic institutional investors (DIIs), hold only 0.01%, suggesting limited institutional interest in the stock. The number of shareholders has slightly decreased from 3,904 in December 2022 to 3,949 in September 2025, reflecting a subtle decline in retail investor engagement. This pattern may raise concerns about investor confidence in the company’s future performance, especially given the volatility in profitability and revenue.
Outlook, Risks, and Final Insight
Camex Ltd faces both opportunities and challenges that will shape its future trajectory. The potential for revenue growth exists if the company can capitalize on operational improvements and market demand for specialty chemicals. However, risks such as fluctuating raw material costs and ongoing profitability concerns pose significant threats. The company’s ability to enhance its operating margins and stabilize revenue will be crucial. Furthermore, the declining promoter stake could signal a lack of confidence, which may affect investor sentiment negatively. In scenarios where Camex successfully implements cost control measures and capitalizes on market trends, it could see improved profitability. Conversely, failure to address operational inefficiencies may lead to continued financial underperformance, impacting its long-term viability in the specialty chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 381 Cr. | 41.5 | 82.2/40.0 | 23.7 | 20.5 | 0.97 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.6 Cr. | 64.3 | 88.8/56.0 | 15.1 | 89.6 | 1.55 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.9 Cr. | 734 | 932/600 | 23.0 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,571 Cr. | 78.8 | 111/68.2 | 23.6 | 22.0 | 0.65 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 638 Cr. | 256 | 393/230 | 22.9 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,858.28 Cr | 719.71 | 66.56 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.58 | 30.33 | 40.36 | 34.13 | 35.22 | 34.37 | 37.59 | 33.84 | 34.39 | 28.21 | 37.21 | 34.37 | 37.22 |
| Expenses | 31.03 | 30.76 | 39.86 | 34.42 | 34.11 | 33.15 | 35.49 | 32.95 | 33.01 | 28.58 | 35.15 | 32.97 | 36.95 |
| Operating Profit | -0.45 | -0.43 | 0.50 | -0.29 | 1.11 | 1.22 | 2.10 | 0.89 | 1.38 | -0.37 | 2.06 | 1.40 | 0.27 |
| OPM % | -1.47% | -1.42% | 1.24% | -0.85% | 3.15% | 3.55% | 5.59% | 2.63% | 4.01% | -1.31% | 5.54% | 4.07% | 0.73% |
| Other Income | 0.58 | 0.35 | 0.62 | 0.37 | 0.44 | 0.52 | 0.25 | 0.33 | 1.15 | 0.29 | -1.01 | 0.09 | 0.08 |
| Interest | 0.18 | 0.34 | 0.23 | 0.25 | 0.21 | 0.12 | 0.18 | 0.33 | 0.45 | 0.31 | 0.24 | 0.22 | 0.40 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.09 | 0.35 | 0.10 | 0.24 |
| Profit before tax | -0.13 | -0.50 | 0.81 | -0.25 | 1.26 | 1.54 | 2.09 | 0.82 | 2.01 | -0.48 | 0.46 | 1.17 | -0.29 |
| Tax % | -46.15% | -14.00% | 23.46% | 0.00% | 21.43% | 24.68% | 25.84% | 24.39% | 27.36% | -35.42% | 69.57% | 23.93% | -3.45% |
| Net Profit | -0.08 | -0.44 | 0.62 | -0.24 | 0.99 | 1.16 | 1.55 | 0.61 | 1.46 | -0.32 | 0.15 | 0.90 | -0.28 |
| EPS in Rs | -0.08 | -0.43 | 0.61 | -0.24 | 0.97 | 1.14 | 1.52 | 0.60 | 1.43 | -0.31 | 0.15 | 0.88 | -0.27 |
Last Updated: December 27, 2025, 4:34 pm
Below is a detailed analysis of the quarterly data for Camex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 37.22 Cr.. The value appears strong and on an upward trend. It has increased from 34.37 Cr. (Jun 2025) to 37.22 Cr., marking an increase of 2.85 Cr..
- For Expenses, as of Sep 2025, the value is 36.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.97 Cr. (Jun 2025) to 36.95 Cr., marking an increase of 3.98 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.27 Cr.. The value appears to be declining and may need further review. It has decreased from 1.40 Cr. (Jun 2025) to 0.27 Cr., marking a decrease of 1.13 Cr..
- For OPM %, as of Sep 2025, the value is 0.73%. The value appears to be declining and may need further review. It has decreased from 4.07% (Jun 2025) to 0.73%, marking a decrease of 3.34%.
- For Other Income, as of Sep 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.22 Cr. (Jun 2025) to 0.40 Cr., marking an increase of 0.18 Cr..
- For Depreciation, as of Sep 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.10 Cr. (Jun 2025) to 0.24 Cr., marking an increase of 0.14 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.29 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Jun 2025) to -0.29 Cr., marking a decrease of 1.46 Cr..
- For Tax %, as of Sep 2025, the value is -3.45%. The value appears to be improving (decreasing) as expected. It has decreased from 23.93% (Jun 2025) to -3.45%, marking a decrease of 27.38%.
- For Net Profit, as of Sep 2025, the value is -0.28 Cr.. The value appears to be declining and may need further review. It has decreased from 0.90 Cr. (Jun 2025) to -0.28 Cr., marking a decrease of 1.18 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.27. The value appears to be declining and may need further review. It has decreased from 0.88 (Jun 2025) to -0.27, marking a decrease of 1.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:01 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 221 | 147 | 102 | 103 | 121 | 140 | 122 | 143 | 162 | 132 | 142 | 134 | 137 |
| Expenses | 215 | 141 | 98 | 99 | 116 | 134 | 119 | 140 | 159 | 131 | 137 | 130 | 134 |
| Operating Profit | 7 | 6 | 4 | 4 | 6 | 7 | 3 | 3 | 2 | 1 | 5 | 4 | 3 |
| OPM % | 3% | 4% | 4% | 4% | 5% | 5% | 3% | 2% | 1% | 0% | 3% | 3% | 2% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 5 | 2 | 1 | 1 | -1 |
| Interest | 4 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Profit before tax | 3 | 2 | 1 | 2 | 3 | 4 | 1 | 2 | 5 | 1 | 5 | 3 | 1 |
| Tax % | 33% | 33% | 33% | 34% | 34% | 23% | 29% | 18% | 17% | 29% | 25% | 32% | |
| Net Profit | 2 | 1 | 1 | 2 | 2 | 3 | 1 | 2 | 4 | 1 | 3 | 2 | 0 |
| EPS in Rs | 1.88 | 1.39 | 0.90 | 1.60 | 2.09 | 3.08 | 0.94 | 1.96 | 4.13 | 0.60 | 3.39 | 1.85 | 0.45 |
| Dividend Payout % | 27% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 0.00% | 100.00% | 0.00% | 50.00% | -66.67% | 100.00% | 100.00% | -75.00% | 200.00% | -33.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 50.00% | 100.00% | -100.00% | 50.00% | -116.67% | 166.67% | 0.00% | -175.00% | 275.00% | -233.33% |
Camex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 2% |
| 3 Years: | -6% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 15% |
| 3 Years: | 0% |
| TTM: | -48% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: December 10, 2025, 4:00 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 10 | 12 | 12 | 14 | 16 | 19 | 20 | 22 | 27 | 27 | 31 | 33 | 33 |
| Borrowings | 36 | 19 | 14 | 20 | 29 | 14 | 3 | 17 | 9 | 5 | 8 | 1 | 6 |
| Other Liabilities | 10 | 10 | 10 | 11 | 11 | 14 | 17 | 27 | 15 | 16 | 13 | 17 | 14 |
| Total Liabilities | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 | 63 |
| Fixed Assets | 6 | 7 | 7 | 8 | 9 | 9 | 9 | 8 | 3 | 2 | 2 | 8 | 8 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 |
| Other Assets | 60 | 43 | 38 | 47 | 57 | 48 | 41 | 69 | 50 | 56 | 59 | 54 | 55 |
| Total Assets | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 | 63 |
Below is a detailed analysis of the balance sheet data for Camex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing). It has decreased from 17.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 55.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2025) to 55.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (33.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -29.00 | -13.00 | -10.00 | -16.00 | -23.00 | -7.00 | 0.00 | -14.00 | -7.00 | -4.00 | -3.00 | 3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 68 | 87 | 98 | 103 | 82 | 77 | 98 | 70 | 82 | 61 | 60 |
| Inventory Days | 18 | 27 | 28 | 44 | 42 | 38 | 31 | 45 | 16 | 31 | 23 | 40 |
| Days Payable | 13 | 25 | 29 | 28 | 21 | 36 | 47 | 71 | 32 | 45 | 32 | 50 |
| Cash Conversion Cycle | 78 | 71 | 86 | 115 | 123 | 83 | 61 | 72 | 54 | 67 | 52 | 51 |
| Working Capital Days | 31 | 40 | 62 | 66 | 69 | 60 | 63 | 79 | 75 | 101 | 84 | 88 |
| ROCE % | 11% | 10% | 8% | 9% | 11% | 12% | 6% | 7% | 7% | 5% | 12% | 9% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Diluted EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Cash EPS (Rs.) | 3.97 | 2.27 | 2.58 | 4.52 | 3.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Revenue From Operations / Share (Rs.) | 175.58 | 147.10 | 129.23 | 144.20 | 126.22 |
| PBDIT / Share (Rs.) | 2.98 | 3.36 | 3.80 | 7.25 | 6.17 |
| PBIT / Share (Rs.) | 2.12 | 2.43 | 2.44 | 6.34 | 5.39 |
| PBT / Share (Rs.) | 3.99 | 1.75 | 1.61 | 4.54 | 3.29 |
| Net Profit / Share (Rs.) | 3.12 | 1.33 | 1.23 | 3.61 | 2.23 |
| NP After MI And SOA / Share (Rs.) | 3.08 | 1.33 | 1.23 | 3.61 | 2.23 |
| PBDIT Margin (%) | 1.69 | 2.28 | 2.93 | 5.02 | 4.89 |
| PBIT Margin (%) | 1.20 | 1.65 | 1.89 | 4.39 | 4.26 |
| PBT Margin (%) | 2.27 | 1.19 | 1.24 | 3.15 | 2.60 |
| Net Profit Margin (%) | 1.77 | 0.90 | 0.95 | 2.50 | 1.76 |
| NP After MI And SOA Margin (%) | 1.75 | 0.90 | 0.95 | 2.50 | 1.76 |
| Return on Networth / Equity (%) | 8.46 | 4.00 | 3.84 | 11.82 | 8.32 |
| Return on Capital Employeed (%) | 4.46 | 5.95 | 7.41 | 18.00 | 14.66 |
| Return On Assets (%) | 4.83 | 1.68 | 2.26 | 5.96 | 3.28 |
| Long Term Debt / Equity (X) | 0.22 | 0.20 | 0.00 | 0.11 | 0.32 |
| Total Debt / Equity (X) | 0.23 | 0.51 | 0.07 | 0.43 | 1.09 |
| Asset Turnover Ratio (%) | 2.29 | 2.16 | 2.19 | 2.22 | 1.95 |
| Current Ratio (X) | 3.74 | 1.85 | 2.10 | 1.99 | 1.86 |
| Quick Ratio (X) | 2.91 | 1.45 | 1.69 | 1.51 | 1.48 |
| Inventory Turnover Ratio (X) | 3.32 | 3.77 | 3.79 | 2.85 | 2.69 |
| Interest Coverage Ratio (X) | 2.34 | 4.98 | 4.56 | 4.04 | 2.95 |
| Interest Coverage Ratio (Post Tax) (X) | 0.98 | 2.97 | 2.48 | 3.01 | 2.07 |
| Enterprise Value (Cr.) | 35.37 | 36.38 | 11.99 | 44.10 | 62.50 |
| EV / Net Operating Revenue (X) | 0.19 | 0.24 | 0.09 | 0.29 | 0.48 |
| EV / EBITDA (X) | 11.63 | 10.59 | 3.09 | 5.96 | 9.91 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| Price / BV (X) | 0.71 | 0.59 | 0.31 | 1.04 | 1.31 |
| Price / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| EarningsYield | 0.11 | 0.06 | 0.12 | 0.11 | 0.06 |
After reviewing the key financial ratios for Camex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 22, the value is 3.97. This value is within the healthy range. It has increased from 2.27 (Mar 21) to 3.97, marking an increase of 1.70.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 175.58. It has increased from 147.10 (Mar 21) to 175.58, marking an increase of 28.48.
- For PBDIT / Share (Rs.), as of Mar 22, the value is 2.98. This value is within the healthy range. It has decreased from 3.36 (Mar 21) to 2.98, marking a decrease of 0.38.
- For PBIT / Share (Rs.), as of Mar 22, the value is 2.12. This value is within the healthy range. It has decreased from 2.43 (Mar 21) to 2.12, marking a decrease of 0.31.
- For PBT / Share (Rs.), as of Mar 22, the value is 3.99. This value is within the healthy range. It has increased from 1.75 (Mar 21) to 3.99, marking an increase of 2.24.
- For Net Profit / Share (Rs.), as of Mar 22, the value is 3.12. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.12, marking an increase of 1.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 3.08. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.08, marking an increase of 1.75.
- For PBDIT Margin (%), as of Mar 22, the value is 1.69. This value is below the healthy minimum of 10. It has decreased from 2.28 (Mar 21) to 1.69, marking a decrease of 0.59.
- For PBIT Margin (%), as of Mar 22, the value is 1.20. This value is below the healthy minimum of 10. It has decreased from 1.65 (Mar 21) to 1.20, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 22, the value is 2.27. This value is below the healthy minimum of 10. It has increased from 1.19 (Mar 21) to 2.27, marking an increase of 1.08.
- For Net Profit Margin (%), as of Mar 22, the value is 1.77. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 21) to 1.77, marking an increase of 0.87.
- For NP After MI And SOA Margin (%), as of Mar 22, the value is 1.75. This value is below the healthy minimum of 8. It has increased from 0.90 (Mar 21) to 1.75, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 22, the value is 8.46. This value is below the healthy minimum of 15. It has increased from 4.00 (Mar 21) to 8.46, marking an increase of 4.46.
- For Return on Capital Employeed (%), as of Mar 22, the value is 4.46. This value is below the healthy minimum of 10. It has decreased from 5.95 (Mar 21) to 4.46, marking a decrease of 1.49.
- For Return On Assets (%), as of Mar 22, the value is 4.83. This value is below the healthy minimum of 5. It has increased from 1.68 (Mar 21) to 4.83, marking an increase of 3.15.
- For Long Term Debt / Equity (X), as of Mar 22, the value is 0.22. This value is within the healthy range. It has increased from 0.20 (Mar 21) to 0.22, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 22, the value is 0.23. This value is within the healthy range. It has decreased from 0.51 (Mar 21) to 0.23, marking a decrease of 0.28.
- For Asset Turnover Ratio (%), as of Mar 22, the value is 2.29. It has increased from 2.16 (Mar 21) to 2.29, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 22, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 21) to 3.74, marking an increase of 1.89.
- For Quick Ratio (X), as of Mar 22, the value is 2.91. This value exceeds the healthy maximum of 2. It has increased from 1.45 (Mar 21) to 2.91, marking an increase of 1.46.
- For Inventory Turnover Ratio (X), as of Mar 22, the value is 3.32. This value is below the healthy minimum of 4. It has decreased from 3.77 (Mar 21) to 3.32, marking a decrease of 0.45.
- For Interest Coverage Ratio (X), as of Mar 22, the value is 2.34. This value is below the healthy minimum of 3. It has decreased from 4.98 (Mar 21) to 2.34, marking a decrease of 2.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 0.98. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 21) to 0.98, marking a decrease of 1.99.
- For Enterprise Value (Cr.), as of Mar 22, the value is 35.37. It has decreased from 36.38 (Mar 21) to 35.37, marking a decrease of 1.01.
- For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 21) to 0.19, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 22, the value is 11.63. This value is within the healthy range. It has increased from 10.59 (Mar 21) to 11.63, marking an increase of 1.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For Price / BV (X), as of Mar 22, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 21) to 0.71, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For EarningsYield, as of Mar 22, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 21) to 0.11, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camex Ltd:
- Net Profit Margin: 1.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.46% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.46% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 68.1 (Industry average Stock P/E: 66.56)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.23
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Camex House, 2nd Floor, Ahmedabad Gujarat 380009 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chandraprakash Chopra | Managing Director |
| Mr. Rajesh Nahata | Executive Director |
| Mr. Rahul Chopra | Non Executive Director |
| Mrs. Tara Jain | Ind. Non-Executive Director |
| Mr. Uttam Bhandari | Ind. Non-Executive Director |
| Mr. Jagrit Sanklecha | Additional Director |
FAQ
What is the intrinsic value of Camex Ltd?
Camex Ltd's intrinsic value (as of 01 January 2026) is ₹109.60 which is 222.35% higher the current market price of ₹34.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹34.7 Cr. market cap, FY2025-2026 high/low of ₹64.0/29.2, reserves of ₹33 Cr, and liabilities of ₹63 Cr.
What is the Market Cap of Camex Ltd?
The Market Cap of Camex Ltd is 34.7 Cr..
What is the current Stock Price of Camex Ltd as on 01 January 2026?
The current stock price of Camex Ltd as on 01 January 2026 is ₹34.0.
What is the High / Low of Camex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Camex Ltd stocks is ₹64.0/29.2.
What is the Stock P/E of Camex Ltd?
The Stock P/E of Camex Ltd is 68.1.
What is the Book Value of Camex Ltd?
The Book Value of Camex Ltd is 42.6.
What is the Dividend Yield of Camex Ltd?
The Dividend Yield of Camex Ltd is 0.00 %.
What is the ROCE of Camex Ltd?
The ROCE of Camex Ltd is 9.07 %.
What is the ROE of Camex Ltd?
The ROE of Camex Ltd is 4.63 %.
What is the Face Value of Camex Ltd?
The Face Value of Camex Ltd is 10.0.